EGFR Tyrosine Kinase Inhibitors Threonine-Tyrosine Kinase Inhibitors Serine-Threonine Kinase Inhibitors Kinase Inhibitors Other Immunotherapy PI3 Kinase Inhibitors IGF Cyclin Dependent Kinase Inhibitors RAS | Colorectal Cancer | Non Small Cell Lung Cancer | Hepatocellular Cancer | Colon Cancer | Head and Neck Cancer | Solid Tumor | Pancreatic Adenocarcinoma | Colorectal Adenocarcinoma |
---|---|---|---|---|---|---|---|---|
sorafenib + BAY86-9766 | ||||||||
ASTX029 | ||||||||
RGX-202 | ||||||||
bevacizumab + PCM-075 | ||||||||
LY3214996 | ||||||||
cetuximab | ||||||||
MEN1611 | ||||||||
BMS-754807 | ||||||||
cetuximab + vemurafenib | ||||||||
sunitinib | ||||||||
trametinib + repotrectinib | ||||||||
ME-522 | ||||||||
adagrasib | ||||||||
sotorasib | ||||||||
ASN007 | ||||||||
SHR-A1307 | ||||||||
panitumumab | ||||||||
erlotinib | ||||||||
Immunotherapy |